Ind-Swift Laboratories Limited
NSE:INDSWFTLAB.NS
134.63 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ind-Swift Laboratories Limited |
Symbool | INDSWFTLAB.NS |
Munteenheid | INR |
Prijs | 134.63 |
Beurswaarde | 7,954,869,347 |
Dividendpercentage | 0% |
52-weken bereik | 81.85 - 186 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Navrattan Munjal |
Website | https://www.indswiftlabs.com |
An error occurred while fetching data.
Over Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)